✦ LIBER ✦

A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer

✍ Scribed by André Planting; Siang Kho; Maria van der Burg; H. Goey; J. Schellens; Martin van den Bent; A. van der Gaast; Maureen de Boer-Dennert; Gerrit Stoter; Jaap Verweij

Publisher: Springer
Year: 1997
Tongue: English
Weight: 107 KB
Volume: 40
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050668

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly docetaxel combi

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Treatment of advanced non-small cell lun

Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C

✍ Paul J. Hesketh; Sualp Tansan; Priscilla B. Caguioa; Ann Hesketh; Rita Blanchard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Phase II study of carboplatin combined w

Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

✍ Lian Jiang; Dao-yuan Wang; Zhi-hua Zhu; Liang-fa Tang; Xin-heng Hou; Hong-da Zha 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Phase I/II study of weekly docetaxel dos

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer

✍ Nobuyuki Yamamoto; Yasumasa Nishimura; Kazuhiko Nakagawa; Kaoru Matsui; Masahiro 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 258 KB

Phase II feasibility study of high dose

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer

✍ Rafael Rosell; Juan Carles; Albert Abad; Jose M. Jimeno; Isabel Moreno; Agustin 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 472 KB

Phase II study of the combination of vin

Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Keigo Tominaga 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 169 KB